img

Global Embolization in Interventional Oncology Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Embolization in Interventional Oncology Market Research Report 2024

According to MRAResearch’s new survey, global Embolization in Interventional Oncology market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Embolization in Interventional Oncology market research.
Key companies engaged in the Embolization in Interventional Oncology industry include Braile Biomedica, Boston Scientific, Cook Medical, Covidien, Merit Medical Systems, Inc., Penumbra, TERUMO MEDICAL CORPORATION, Stryker and Terumo, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Embolization in Interventional Oncology were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Embolization in Interventional Oncology market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Embolization in Interventional Oncology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Braile Biomedica
Boston Scientific
Cook Medical
Covidien
Merit Medical Systems, Inc.
Penumbra
TERUMO MEDICAL CORPORATION
Stryker
Terumo
Segment by Type
Embolization Devices
Ablation Devices
Support Devices

Segment by Application


Hospitals
Specialty Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Embolization in Interventional Oncology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Embolization in Interventional Oncology Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Embolization Devices
1.2.3 Ablation Devices
1.2.4 Support Devices
1.3 Market by Application
1.3.1 Global Embolization in Interventional Oncology Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Embolization in Interventional Oncology Market Perspective (2018-2033)
2.2 Embolization in Interventional Oncology Growth Trends by Region
2.2.1 Global Embolization in Interventional Oncology Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Embolization in Interventional Oncology Historic Market Size by Region (2018-2023)
2.2.3 Embolization in Interventional Oncology Forecasted Market Size by Region (2024-2033)
2.3 Embolization in Interventional Oncology Market Dynamics
2.3.1 Embolization in Interventional Oncology Industry Trends
2.3.2 Embolization in Interventional Oncology Market Drivers
2.3.3 Embolization in Interventional Oncology Market Challenges
2.3.4 Embolization in Interventional Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Embolization in Interventional Oncology Players by Revenue
3.1.1 Global Top Embolization in Interventional Oncology Players by Revenue (2018-2023)
3.1.2 Global Embolization in Interventional Oncology Revenue Market Share by Players (2018-2023)
3.2 Global Embolization in Interventional Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Embolization in Interventional Oncology Revenue
3.4 Global Embolization in Interventional Oncology Market Concentration Ratio
3.4.1 Global Embolization in Interventional Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Embolization in Interventional Oncology Revenue in 2022
3.5 Embolization in Interventional Oncology Key Players Head office and Area Served
3.6 Key Players Embolization in Interventional Oncology Product Solution and Service
3.7 Date of Enter into Embolization in Interventional Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Embolization in Interventional Oncology Breakdown Data by Type
4.1 Global Embolization in Interventional Oncology Historic Market Size by Type (2018-2023)
4.2 Global Embolization in Interventional Oncology Forecasted Market Size by Type (2024-2033)
5 Embolization in Interventional Oncology Breakdown Data by Application
5.1 Global Embolization in Interventional Oncology Historic Market Size by Application (2018-2023)
5.2 Global Embolization in Interventional Oncology Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Embolization in Interventional Oncology Market Size (2018-2033)
6.2 North America Embolization in Interventional Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Embolization in Interventional Oncology Market Size by Country (2018-2023)
6.4 North America Embolization in Interventional Oncology Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Embolization in Interventional Oncology Market Size (2018-2033)
7.2 Europe Embolization in Interventional Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Embolization in Interventional Oncology Market Size by Country (2018-2023)
7.4 Europe Embolization in Interventional Oncology Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Embolization in Interventional Oncology Market Size (2018-2033)
8.2 Asia-Pacific Embolization in Interventional Oncology Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Embolization in Interventional Oncology Market Size by Region (2018-2023)
8.4 Asia-Pacific Embolization in Interventional Oncology Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Embolization in Interventional Oncology Market Size (2018-2033)
9.2 Latin America Embolization in Interventional Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Embolization in Interventional Oncology Market Size by Country (2018-2023)
9.4 Latin America Embolization in Interventional Oncology Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Embolization in Interventional Oncology Market Size (2018-2033)
10.2 Middle East & Africa Embolization in Interventional Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Embolization in Interventional Oncology Market Size by Country (2018-2023)
10.4 Middle East & Africa Embolization in Interventional Oncology Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Braile Biomedica
11.1.1 Braile Biomedica Company Detail
11.1.2 Braile Biomedica Business Overview
11.1.3 Braile Biomedica Embolization in Interventional Oncology Introduction
11.1.4 Braile Biomedica Revenue in Embolization in Interventional Oncology Business (2018-2023)
11.1.5 Braile Biomedica Recent Development
11.2 Boston Scientific
11.2.1 Boston Scientific Company Detail
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Embolization in Interventional Oncology Introduction
11.2.4 Boston Scientific Revenue in Embolization in Interventional Oncology Business (2018-2023)
11.2.5 Boston Scientific Recent Development
11.3 Cook Medical
11.3.1 Cook Medical Company Detail
11.3.2 Cook Medical Business Overview
11.3.3 Cook Medical Embolization in Interventional Oncology Introduction
11.3.4 Cook Medical Revenue in Embolization in Interventional Oncology Business (2018-2023)
11.3.5 Cook Medical Recent Development
11.4 Covidien
11.4.1 Covidien Company Detail
11.4.2 Covidien Business Overview
11.4.3 Covidien Embolization in Interventional Oncology Introduction
11.4.4 Covidien Revenue in Embolization in Interventional Oncology Business (2018-2023)
11.4.5 Covidien Recent Development
11.5 Merit Medical Systems, Inc.
11.5.1 Merit Medical Systems, Inc. Company Detail
11.5.2 Merit Medical Systems, Inc. Business Overview
11.5.3 Merit Medical Systems, Inc. Embolization in Interventional Oncology Introduction
11.5.4 Merit Medical Systems, Inc. Revenue in Embolization in Interventional Oncology Business (2018-2023)
11.5.5 Merit Medical Systems, Inc. Recent Development
11.6 Penumbra
11.6.1 Penumbra Company Detail
11.6.2 Penumbra Business Overview
11.6.3 Penumbra Embolization in Interventional Oncology Introduction
11.6.4 Penumbra Revenue in Embolization in Interventional Oncology Business (2018-2023)
11.6.5 Penumbra Recent Development
11.7 TERUMO MEDICAL CORPORATION
11.7.1 TERUMO MEDICAL CORPORATION Company Detail
11.7.2 TERUMO MEDICAL CORPORATION Business Overview
11.7.3 TERUMO MEDICAL CORPORATION Embolization in Interventional Oncology Introduction
11.7.4 TERUMO MEDICAL CORPORATION Revenue in Embolization in Interventional Oncology Business (2018-2023)
11.7.5 TERUMO MEDICAL CORPORATION Recent Development
11.8 Stryker
11.8.1 Stryker Company Detail
11.8.2 Stryker Business Overview
11.8.3 Stryker Embolization in Interventional Oncology Introduction
11.8.4 Stryker Revenue in Embolization in Interventional Oncology Business (2018-2023)
11.8.5 Stryker Recent Development
11.9 Terumo
11.9.1 Terumo Company Detail
11.9.2 Terumo Business Overview
11.9.3 Terumo Embolization in Interventional Oncology Introduction
11.9.4 Terumo Revenue in Embolization in Interventional Oncology Business (2018-2023)
11.9.5 Terumo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Embolization in Interventional Oncology Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Embolization Devices
Table 3. Key Players of Ablation Devices
Table 4. Key Players of Support Devices
Table 5. Global Embolization in Interventional Oncology Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Embolization in Interventional Oncology Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Embolization in Interventional Oncology Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Embolization in Interventional Oncology Market Share by Region (2018-2023)
Table 9. Global Embolization in Interventional Oncology Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Embolization in Interventional Oncology Market Share by Region (2024-2033)
Table 11. Embolization in Interventional Oncology Market Trends
Table 12. Embolization in Interventional Oncology Market Drivers
Table 13. Embolization in Interventional Oncology Market Challenges
Table 14. Embolization in Interventional Oncology Market Restraints
Table 15. Global Embolization in Interventional Oncology Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Embolization in Interventional Oncology Market Share by Players (2018-2023)
Table 17. Global Top Embolization in Interventional Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Embolization in Interventional Oncology as of 2022)
Table 18. Ranking of Global Top Embolization in Interventional Oncology Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Embolization in Interventional Oncology Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Embolization in Interventional Oncology Product Solution and Service
Table 22. Date of Enter into Embolization in Interventional Oncology Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Embolization in Interventional Oncology Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Embolization in Interventional Oncology Revenue Market Share by Type (2018-2023)
Table 26. Global Embolization in Interventional Oncology Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Embolization in Interventional Oncology Revenue Market Share by Type (2024-2033)
Table 28. Global Embolization in Interventional Oncology Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Embolization in Interventional Oncology Revenue Market Share by Application (2018-2023)
Table 30. Global Embolization in Interventional Oncology Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Embolization in Interventional Oncology Revenue Market Share by Application (2024-2033)
Table 32. North America Embolization in Interventional Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Embolization in Interventional Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Embolization in Interventional Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Embolization in Interventional Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Embolization in Interventional Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Embolization in Interventional Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Embolization in Interventional Oncology Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Embolization in Interventional Oncology Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Embolization in Interventional Oncology Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Embolization in Interventional Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Embolization in Interventional Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Embolization in Interventional Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Embolization in Interventional Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Embolization in Interventional Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Embolization in Interventional Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 47. Braile Biomedica Company Detail
Table 48. Braile Biomedica Business Overview
Table 49. Braile Biomedica Embolization in Interventional Oncology Product
Table 50. Braile Biomedica Revenue in Embolization in Interventional Oncology Business (2018-2023) & (US$ Million)
Table 51. Braile Biomedica Recent Development
Table 52. Boston Scientific Company Detail
Table 53. Boston Scientific Business Overview
Table 54. Boston Scientific Embolization in Interventional Oncology Product
Table 55. Boston Scientific Revenue in Embolization in Interventional Oncology Business (2018-2023) & (US$ Million)
Table 56. Boston Scientific Recent Development
Table 57. Cook Medical Company Detail
Table 58. Cook Medical Business Overview
Table 59. Cook Medical Embolization in Interventional Oncology Product
Table 60. Cook Medical Revenue in Embolization in Interventional Oncology Business (2018-2023) & (US$ Million)
Table 61. Cook Medical Recent Development
Table 62. Covidien Company Detail
Table 63. Covidien Business Overview
Table 64. Covidien Embolization in Interventional Oncology Product
Table 65. Covidien Revenue in Embolization in Interventional Oncology Business (2018-2023) & (US$ Million)
Table 66. Covidien Recent Development
Table 67. Merit Medical Systems, Inc. Company Detail
Table 68. Merit Medical Systems, Inc. Business Overview
Table 69. Merit Medical Systems, Inc. Embolization in Interventional Oncology Product
Table 70. Merit Medical Systems, Inc. Revenue in Embolization in Interventional Oncology Business (2018-2023) & (US$ Million)
Table 71. Merit Medical Systems, Inc. Recent Development
Table 72. Penumbra Company Detail
Table 73. Penumbra Business Overview
Table 74. Penumbra Embolization in Interventional Oncology Product
Table 75. Penumbra Revenue in Embolization in Interventional Oncology Business (2018-2023) & (US$ Million)
Table 76. Penumbra Recent Development
Table 77. TERUMO MEDICAL CORPORATION Company Detail
Table 78. TERUMO MEDICAL CORPORATION Business Overview
Table 79. TERUMO MEDICAL CORPORATION Embolization in Interventional Oncology Product
Table 80. TERUMO MEDICAL CORPORATION Revenue in Embolization in Interventional Oncology Business (2018-2023) & (US$ Million)
Table 81. TERUMO MEDICAL CORPORATION Recent Development
Table 82. Stryker Company Detail
Table 83. Stryker Business Overview
Table 84. Stryker Embolization in Interventional Oncology Product
Table 85. Stryker Revenue in Embolization in Interventional Oncology Business (2018-2023) & (US$ Million)
Table 86. Stryker Recent Development
Table 87. Terumo Company Detail
Table 88. Terumo Business Overview
Table 89. Terumo Embolization in Interventional Oncology Product
Table 90. Terumo Revenue in Embolization in Interventional Oncology Business (2018-2023) & (US$ Million)
Table 91. Terumo Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Embolization in Interventional Oncology Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Embolization in Interventional Oncology Market Share by Type: 2022 VS 2033
Figure 3. Embolization Devices Features
Figure 4. Ablation Devices Features
Figure 5. Support Devices Features
Figure 6. Global Embolization in Interventional Oncology Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Embolization in Interventional Oncology Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Embolization in Interventional Oncology Report Years Considered
Figure 11. Global Embolization in Interventional Oncology Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Embolization in Interventional Oncology Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Embolization in Interventional Oncology Market Share by Region: 2022 VS 2033
Figure 14. Global Embolization in Interventional Oncology Market Share by Players in 2022
Figure 15. Global Top Embolization in Interventional Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Embolization in Interventional Oncology as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Embolization in Interventional Oncology Revenue in 2022
Figure 17. North America Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Embolization in Interventional Oncology Market Share by Country (2018-2033)
Figure 19. United States Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Embolization in Interventional Oncology Market Share by Country (2018-2033)
Figure 23. Germany Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Embolization in Interventional Oncology Market Share by Region (2018-2033)
Figure 31. China Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Embolization in Interventional Oncology Market Share by Country (2018-2033)
Figure 39. Mexico Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Embolization in Interventional Oncology Market Share by Country (2018-2033)
Figure 43. Turkey Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Embolization in Interventional Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Braile Biomedica Revenue Growth Rate in Embolization in Interventional Oncology Business (2018-2023)
Figure 46. Boston Scientific Revenue Growth Rate in Embolization in Interventional Oncology Business (2018-2023)
Figure 47. Cook Medical Revenue Growth Rate in Embolization in Interventional Oncology Business (2018-2023)
Figure 48. Covidien Revenue Growth Rate in Embolization in Interventional Oncology Business (2018-2023)
Figure 49. Merit Medical Systems, Inc. Revenue Growth Rate in Embolization in Interventional Oncology Business (2018-2023)
Figure 50. Penumbra Revenue Growth Rate in Embolization in Interventional Oncology Business (2018-2023)
Figure 51. TERUMO MEDICAL CORPORATION Revenue Growth Rate in Embolization in Interventional Oncology Business (2018-2023)
Figure 52. Stryker Revenue Growth Rate in Embolization in Interventional Oncology Business (2018-2023)
Figure 53. Terumo Revenue Growth Rate in Embolization in Interventional Oncology Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed